Atlas Trials

Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer

Clinical trial NCT03949283 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03949283
Sponsor
Cordgenics, LLC
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Recurrent Ovarian CarcinomaPlatinum-resistant Ovarian Cancer
Start date
2019-07-26
Primary completion
2024-06-30
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.